https://www.zonebourse.com/cours/action/CELLDEX-THERAPEUTICS-INC-54658351/actualite/Celldex-Therapeutics-annonce-des-resultats-positifs-de-l-etude-de-phase-2-du-barzolvolimab-dans-l-45253095/?utm_source=telegram&utm_medium=social&utm_campaign=share